1. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study;Wolf;Cancer,2008
2. Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer;Paik;J Clin Oncol,2005
3. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004
4. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;Paik;J Clin Oncol,2006
5. National Comprehensive Cancer Network. NCCN Clinical Practice Guideline in Oncology: Breast Cancer (version 3.2013). http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed May 2, 2013.